The overall goal of this proposal is to identify the genetic changes responsible for initiation of ovarian cancer. The identification of the mutations that occur early in tumorigenesis could enable the development of molecular approaches for earlier diagnosis, at the time when current therapeutic strategies have a high cure rate. Since the overwhelming majority of ovarian tumors arise from the surface epithelium, the development of ovarian surface epithelial cell lines would serve as a strong foundation for the molecular analysis of events surrounding the initiation of ovarian carcinogenesis. To identify the genetic changes responsible for the earliest steps in malignant transformation in the absence of the multiple molecular and cytogenetic alterations commonly observed in advanced ovarian tumors, a cell culture model will be utilized (Specific Aim 1: Induce spontaneous transformation of ovarian surface epithelial cells from oophorectomy specimens obtained from individuals with different relative risks for development of ovarian cancer). Preliminary studies included in this proposal indicate that human ovarian surface epithelial cells isolated and placed in tissue culture to stimulate growth can undergo spontaneous malignant transformation. Furthermore, these cell lines show molecular and cytogenetic changes which are consistent with the genetic abnormalities observed in ovarian carcinomas, suggesting that this cell culture system has the potential to identify candidate genes involved in ovarian carcinogenesis. The work proposed, is designed to carefully evaluate the genetic changes observed in spontaneously transformed human surface epithelial cells by LOH analysis, whole genome scanning, and high resolution cytogenetic techniques and to determine their relationship to the abnormalities found in fresh ovarian tumors (Specific Aim 2: Compare the allelotypes of malignantly transformed human ovarian surface epithelial cells and ovarian tumors in order to differentiate the genetic changes associated with disease initiation from those which arise during progression and Specific Aim 3: Use whole genome scanning and cytogenetic approaches to identify the location of candidate gene(s) responsible for the initiation of the malignant phenotype of human ovarian surface epithelial cells). These approaches have the potential to identify critical genetic changes relevant to initiation of clinical ovarian cancer, all in the absence of the numerous genetic abnormalities characteristic of ovarian cancer at diagnosis. The long range goal is to determine the causal role in ovarian carcinogenesis of these candidate genes identified through implementation of this proposal. Therefore, these studies should provide important insights into the specific genetic alterations involved in the pathogenesis of ovarian cancer, increase the understanding of the basic biology of this disease, and ultimately benefit future patients.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA060643-01
Application #
3204146
Study Section
Special Emphasis Panel (SRC (50))
Project Start
1993-09-30
Project End
1996-09-29
Budget Start
1993-09-30
Budget End
1994-09-29
Support Year
1
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Fox Chase Cancer Center
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19111
Abdollahi, A; Godwin, A K; Miller, P D et al. (1997) Identification of a gene containing zinc-finger motifs based on lost expression in malignantly transformed rat ovarian surface epithelial cells. Cancer Res 57:2029-34
Dyck, H G; Hamilton, T C; Godwin, A K et al. (1996) Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int J Cancer 69:429-36
Salazar, H; Godwin, A K; Daly, M B et al. (1996) Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies. J Natl Cancer Inst 88:1810-20
Rebbeck, T R; Godwin, A K; Buetow, K H (1996) Variability in loss of constitutional heterozygosity across loci and among individuals: association with candidate genes in ductal breast carcinoma. Mol Carcinog 17:117-25
Berman, D B; Costalas, J; Schultz, D C et al. (1996) A common mutation in BRCA2 that predisposes to a variety of cancers is found in both Jewish Ashkenazi and non-Jewish individuals. Cancer Res 56:3409-14
Schultz, D C; Vanderveer, L; Berman, D B et al. (1996) Identification of two candidate tumor suppressor genes on chromosome 17p13.3. Cancer Res 56:1997-2002
Berman, D B; Wagner-Costalas, J; Schultz, D C et al. (1996) Two distinct origins of a common BRCA1 mutation in breast-ovarian cancer families: a genetic study of 15 185delAG-mutation kindreds. Am J Hum Genet 58:1166-76
Godwin, A K; Miller, P D; Getts, L A et al. (1995) Retroviral-like sequences specifically expressed in the rat ovary detect genetic differences between normal and transformed rat ovarian surface epithelial cells. Endocrinology 136:4640-9
Schultz, D C; Vanderveer, L; Buetow, K H et al. (1995) Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Cancer Res 55:2150-7
Auersperg, N; Maines-Bandiera, S; Booth, J H et al. (1995) Expression of two mucin antigens in cultured human ovarian surface epithelium: influence of a family history of ovarian cancer. Am J Obstet Gynecol 173:558-65

Showing the most recent 10 out of 12 publications